| St. Jude Medical, Inc. (St. Jude) develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiology and cardiac surgery and atrial fibrillation therapy areas and implantable neurostimulation devices for the management of chronic pain. The Company operates in four business segments: Cardiac Rhythm Management (CRM), Cardiovascular (CV), Atrial Fibrillation (AF) and Advanced Neuromodulation Systems (ANS). During the fiscal year ended December 29, 2007 (fiscal 2007), St. Jude combined its former Cardiac Surgery and Cardiology operating segments to form the CV operating segment, which focuses on the cardiac surgery and cardiology therapy areas. The principal geographic markets for its products are the United States, Europe, Japan and Asia Pacific. In July 2008, the Company completed the previously announced acquisition of EP MedSystems, Inc. |
